MRTX

Mirati Therapeutics Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

MRTX price

Mirati Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MRTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals MRTX

Valuation

P/E

0.00

Sector -3.50

Industry -3.50

P/BV

0.00

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

Sector -214.99

Industry -214.99

EV/EBIT

Sector -47.59

Industry -47.59

P/EBITDA

Sector -21.41

Industry -21.41

P/EBIT

Sector -28.65

Industry -28.65

P/Total Assets

Sector 1.19

Industry 1.19

P/Net Current Assets

Sector -11.97

Industry -11.97

P/Working Capital

Sector -167.95

Industry -167.95

EPS

-11.17

Sector -1.81

Industry -1.81

BVPS

14.56

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

91.33%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-1,055.91%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-1,062.71%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.01

Sector 0.02

Industry 0.02

Profitability

ROE

-76.69%

Sector -56.04%

Industry -56.04%

ROA

-64.25%

Sector -60.31%

Industry -60.31%

ROIC

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

Sector -8.06

Industry -8.06

Net Debt / Equity

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

Sector -0.85

Industry -0.85

Equity/Assets

0.84

Sector 0.46

Industry 0.46

Liabilities/Assets

0.16

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-11.93%

Sector -

Industry -

5Y Earnings CAGR

4.53%

Sector -

Industry -

Fundamentals MRTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MRTX Mirati Therapeutics Inc.	$0.00	-	0.00%	0.00	0.00	-76.69%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MRTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Mirati Therapeutics

Mirati Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

13 years

Founded: 2013

2013

Time since IPO - 13 years

201

Employees

Mirati Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $946.47 million.

The company employs approximately 201 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Mirati Therapeutics Inc. reported $38.19 million in revenue, generating net income of $-725.88 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MRTX.

Market cap

Net worth

$946.47 million

$946,465,000.00

Assets

$1.13 billion

$1,129,708,000.00

Total Shares Outstanding

64.99 million

64,993,000

Average Daily Trading Volume

$1.83 million

$1,834,581.56

Sector

Health Care

Industry

Biotechnology

MRTX

MRTX revenue and profits

Financial Results MRTX

DRAG THE FRAME TO SEE MORE DATA

MRTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Mirati Therapeutics (MRTX) today?

A cotação de Mirati Therapeutics (MRTX) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Mirati Therapeutics (MRTX) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Mirati Therapeutics (MRTX) e dados de ações do Ibovespa e mercados internacionais.

Quando Mirati Therapeutics (MRTX) paga dividendos?

Mirati Therapeutics (MRTX) não distribuiu dividendos no último ano.

Is Mirati Therapeutics (MRTX) a good investment?

Atualmente, Mirati Therapeutics (MRTX) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de -172% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Mirati Therapeutics (MRTX) stock?

Investir em ações de Mirati Therapeutics (MRTX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Mirati Therapeutics (MRTX) yield today?

A rentabilidade de Mirati Therapeutics (MRTX) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Mirati Therapeutics (MRTX) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MRTX

Mirati Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MRTX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING MRTX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Mirati Therapeutics

Mirati Therapeutics Inc.

United States

13 years

2013

201

PROFIT X PRICE MRTX

Financial Results MRTX

MRTX cash flow

Asset, Revenue and Profit Growth - MRTX

MRTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions